Ignite Creation Date:
2025-12-24 @ 9:41 PM
Ignite Modification Date:
2026-05-14 @ 1:40 PM
Study NCT ID:
NCT05284032
Status:
TERMINATED
Last Update Posted:
2024-07-31
First Post:
2022-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)
Sponsor:
Firas El Chaer, MD
Organization: